CoChat

The Effect of an α-7 Nicotinic Allosteric Modulator PNU120596 and NMDA Receptor Antagonist Memantine on Depressive-like Behavior Induced by LPS in Mice: The Involvement of Brain Microglia

Open access

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

Nicotinic acetylcholine receptors (nAChRs), particularly the α7 nAChR, play a critical role in neuroinflammation and microglial activation associated with major depressive disorder (MDD). Microglial quinolinic acid (QUIN), which is synthesized by 3-hydroxyanthranilic acid dioxygenase (HAAO), is an N-methyl-D-aspartate (NMDA) receptor agonist and has been implicated in the development of MDD-related symptoms. In the present study, we assessed the effects of PNU120596, an α7 nAChR positive allosteric modulator (PAM), on HAAO expression and QUIN formation in the hippocampus and prefrontal cortex. We also investigated the effects of memantine, an NMDA receptor antagonist, alone and in combination with PNU120596 on cognitive deficit and depressive-like behaviors induced by lipopolysaccharide (LPS) in mice using the Y-maze and forced swim test, respectively. LPS (1 mg/kg, i.p.) elevated HAAO expression and QUIN formation in the hippocampus and prefrontal cortex, which were reduced with pretreatment with PNU120596 (4 mg/kg, i.p.). Furthermore, memantine (1 or 3 mg/kg, i.p.) prevented the cognitive deficit and depressive-like behaviors induced by LPS in mice. Together, these results suggest that the antidepressant-like effects of PNU120596 are mediated by attenuation of LPS-induced QUIN formation. Therefore, α7 nAChR PAM could be a potential therapeutic candidate for MDD associated with neurotoxic glutamatergic transmission.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/brainsci12111493

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (A) PNU120596 (PNU) reduced LPS-elevated HAAO expression in the hippocampus and prefrontal cortex. LPS (1 mg/kg) significantly increased HAAO expression in the hippocampus (p < 0.01) or prefrontal cortex (p < 0.05) than controls. PNU (4 mg/kg) significantly (p < 0.05) reduced HAAO expression in the hippocampus or prefrontal cortex than the LPS-treated group. (B) Effects of PNU on the HAAO immunoreactivity in the DG and CA1 regions of the mouse hippocampus and prefrontal cortex. LPS (1 mg/kg) significantly elevated HAAO expression in DG (p < 0.01), CA1 (p < 0.05) or prefrontal cortex (p < 0.01) than control group. PNU (4 mg/kg) significantly (p < 0.05) attenuated HAAO expression in the DG, CA1 or prefrontal cortex than the LPS-treated group. (C) Representative images of immunofluorescence in DG, CA1, and prefrontal cortex. Magnification 20×, scale bar = 50 μm. # p < 0.05 or ## p < 0.01, LPS (1 mg/kg) vs. control; * p < 0.05, PNU (4 mg/kg) + LPS vs. LPS alone; + p < 0.05, MLA (3 mg/kg) + PNU (4 mg/kg) + LPS vs. PNU (4 mg/kg) + LPS. Data are expressed as mean ± SEM (4–7 mice/group).
Figure 1 (A) PNU120596 (PNU) reduced LPS-elevated HAAO expression in the hippocampus and prefrontal cortex. LPS (1 mg/kg) significantly increased HAAO expression in the hippocampus (p < 0.01) or prefrontal cortex (p < 0.05) than controls. PNU (4 mg/kg) significantly (p < 0.05) reduced HAAO expression in the hippocampus or prefrontal cortex than the LPS-treated group. (B) Effects of PNU on the HAAO immunoreactivity in the DG and CA1 regions of the mouse hippocampus and prefrontal cortex. LPS (1 mg/kg) significantly elevated HAAO expression in DG (p < 0.01), CA1 (p < 0.05) or prefrontal cortex (p < 0.01) than control group. PNU (4 mg/kg) significantly (p < 0.05) attenuated HAAO expression in the DG, CA1 or prefrontal cortex than the LPS-treated group. (C) Representative images of immunofluorescence in DG, CA1, and prefrontal cortex. Magnification 20×, scale bar = 50 μm. # p < 0.05 or ## p < 0.01, LPS (1 mg/kg) vs. control; * p < 0.05, PNU (4 mg/kg) + LPS vs. LPS alone; + p < 0.05, MLA (3 mg/kg) + PNU (4 mg/kg) + LPS vs. PNU (4 mg/kg) + LPS. Data are expressed as mean ± SEM (4–7 mice/group).CC BY · PubMed Central
Figure 2 (A) Effects of PNU120596 (PNU) on the QUIN-immunoreactivity (QUIN-IR) in DG and CA1 regions of the hippocampus and prefrontal cortex. LPS (1 mg/kg) significantly increased QUIN-IR in DG (p < 0.05), CA1 (p < 0.01) or prefrontal cortex (p < 0.05) compared to control. PNU (4 mg/kg) reduced QUIN in the DG, CA1 or prefrontal cortex than the LPS-treated group. (B) Representative immunofluorescence images in DG, CA1, and prefrontal cortex. Magnification 20×, scale bar = 50 μm. # p < 0.05 or ## p < 0.01, LPS (1 mg/kg) vs. control; * p < 0.05, PNU (4 mg/kg) plus LPS vs. LPS alone. Data are expressed as mean ± SEM (n = 6/group).
Figure 2 (A) Effects of PNU120596 (PNU) on the QUIN-immunoreactivity (QUIN-IR) in DG and CA1 regions of the hippocampus and prefrontal cortex. LPS (1 mg/kg) significantly increased QUIN-IR in DG (p < 0.05), CA1 (p < 0.01) or prefrontal cortex (p < 0.05) compared to control. PNU (4 mg/kg) reduced QUIN in the DG, CA1 or prefrontal cortex than the LPS-treated group. (B) Representative immunofluorescence images in DG, CA1, and prefrontal cortex. Magnification 20×, scale bar = 50 μm. # p < 0.05 or ## p < 0.01, LPS (1 mg/kg) vs. control; * p < 0.05, PNU (4 mg/kg) plus LPS vs. LPS alone. Data are expressed as mean ± SEM (n = 6/group).CC BY · PubMed Central
Figure 3 Effects of memantine (MEM, 1 or 3 mg/kg) on LPS-induced depressive-like behavior. (A) Experimental timeline for drug administrations and behavioral tests. (B) Effects of MEM on locomotor activity. The treatments did not show significant effects on the total distance traveled. (C) Effects of MEM on the percent of spontaneous alternations in Y-maze. MEM (3 mg/kg) significantly (p < 0.05) enhanced spontaneous alternations than LPS treated mice. (D) MEM (3 mg/kg) significantly (p < 0.001) prevented LPS-induced increase in immobility time in the TST. (E) MEM significantly (p < 0.01) prevented the LPS-induced increase in immobility time in the FST. ##p < 0.01 or ### p < 0.001, vehicle/LPS (1 mg/kg) vs. vehicle/control; * p < 0.05, ** p < 0.01 or *** p < 0.001, MEM (3 mg/kg) plus LPS vs. vehicle/LPS. Data are expressed as mean ± SEM (n = 6–7/group).
Figure 3 Effects of memantine (MEM, 1 or 3 mg/kg) on LPS-induced depressive-like behavior. (A) Experimental timeline for drug administrations and behavioral tests. (B) Effects of MEM on locomotor activity. The treatments did not show significant effects on the total distance traveled. (C) Effects of MEM on the percent of spontaneous alternations in Y-maze. MEM (3 mg/kg) significantly (p < 0.05) enhanced spontaneous alternations than LPS treated mice. (D) MEM (3 mg/kg) significantly (p < 0.001) prevented LPS-induced increase in immobility time in the TST. (E) MEM significantly (p < 0.01) prevented the LPS-induced increase in immobility time in the FST. ##p < 0.01 or ### p < 0.001, vehicle/LPS (1 mg/kg) vs. vehicle/control; * p < 0.05, ** p < 0.01 or *** p < 0.001, MEM (3 mg/kg) plus LPS vs. vehicle/LPS. Data are expressed as mean ± SEM (n = 6–7/group).CC BY · PubMed Central
Figure 4 The effects of PNU120596 (PNU, 1 mg/kg) in combination with memantine (MEM, 1 mg/kg) on LPS-induced depressive-like behavior. (A) Experimental timeline for drug administrations and behavioral assays. (B) The effect of PNU with MEM on total distance traveled (m). The two drugs did not show significantly alter the total distance traveled. (C) The effect of PNU with MEM on spontaneous alternations (%) in Y-maze. Treatment with PNU and MEM together significantly (p < 0.01) increased spontaneous alternations compared to the LPS-treated group. (D) Coadministration of PNU and MEM significantly (p < 0.01) decreased immobility time compared to the LPS-treated mice. (E) Coadministration of PNU and MEM significantly (p < 0.01) decreased immobility time in the FST than the LPS-treated mice. # p < 0.05, ## p < 0.01 or ### p < 0.001, vehicle/LPS (1 mg/kg) vs. vehicle/control; ** p < 0.01, PNU (1 mg/kg) + MEM (1 mg/kg)/LPS vs. vehicle/LPS. Data are expressed as mean ± SEM, n = 6–10/group.
Figure 4 The effects of PNU120596 (PNU, 1 mg/kg) in combination with memantine (MEM, 1 mg/kg) on LPS-induced depressive-like behavior. (A) Experimental timeline for drug administrations and behavioral assays. (B) The effect of PNU with MEM on total distance traveled (m). The two drugs did not show significantly alter the total distance traveled. (C) The effect of PNU with MEM on spontaneous alternations (%) in Y-maze. Treatment with PNU and MEM together significantly (p < 0.01) increased spontaneous alternations compared to the LPS-treated group. (D) Coadministration of PNU and MEM significantly (p < 0.01) decreased immobility time compared to the LPS-treated mice. (E) Coadministration of PNU and MEM significantly (p < 0.01) decreased immobility time in the FST than the LPS-treated mice. # p < 0.05, ## p < 0.01 or ### p < 0.001, vehicle/LPS (1 mg/kg) vs. vehicle/control; ** p < 0.01, PNU (1 mg/kg) + MEM (1 mg/kg)/LPS vs. vehicle/LPS. Data are expressed as mean ± SEM, n = 6–10/group.CC BY · PubMed Central
Figure 5 A schematic diagram of how LPS may induce depression-like behaviors and how the α7 nAChR and NMDA receptor antagonists together exert antidepressant-like effects in LPS-mediated inflammatory model of MDD. (1) PNU120596 positively modulates the α7 nAChR via the allosteric binding site. This activation prevents LPS-induced increase in HAAO expression and QUIN formation in the hippocampus (HPC) and prefrontal cortex (PFC). (2) Inhibition of the NMDA receptor-mediated glutamatergic neurotransmission, induced by QUIN, by memantine reduced LPS-induced depression-like behavior. (3) Memantine enhances the antidepressant-like effects of PNU120596, suggesting the interaction between α7 nAChR and NMDA receptor mediating depression-like behavior in mice. →: stimulation; ─┤: inhibition.
Figure 5 A schematic diagram of how LPS may induce depression-like behaviors and how the α7 nAChR and NMDA receptor antagonists together exert antidepressant-like effects in LPS-mediated inflammatory model of MDD. (1) PNU120596 positively modulates the α7 nAChR via the allosteric binding site. This activation prevents LPS-induced increase in HAAO expression and QUIN formation in the hippocampus (HPC) and prefrontal cortex (PFC). (2) Inhibition of the NMDA receptor-mediated glutamatergic neurotransmission, induced by QUIN, by memantine reduced LPS-induced depression-like behavior. (3) Memantine enhances the antidepressant-like effects of PNU120596, suggesting the interaction between α7 nAChR and NMDA receptor mediating depression-like behavior in mice. →: stimulation; ─┤: inhibition.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 19

Metadata

Authors
Alzarea, S., Abbas, M., Ronan, P. J., Lutfy, K., & Rahman, S.
Affiliations
  • South Dakota State University (US)
  • University of South Dakota (US)
  • Western University of Health Sciences (US)
Corresponding author
Rahman, Shafiqur
Venue
Brain Sciences
Publisher
MDPI AG
Published
2022-11-03
Volume
12
Issue
11
Pages
1493
ISSN
2076-3425 (ISSN-L)
OpenAlex
W4308331879
Cited by
17
References
52
Citations by year
2026: 1 · 2025: 5 · 2024: 8 · 2023: 3
FWCI
1.39
Type
journal article
Language
en
Open access
Locations
  • Brain Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • The South Dakota State University (SDSU) Research Foundation (S.R.), Department of Pharmaceutical Sciences of SDSU (I01BX004712, NIMH R01 MH122954, NIH NIGMS U54GM128729)
  • The College of Pharmacy (S.R.) (I01BX004712, NIMH R01 MH122954, NIH NIGMS U54GM128729)
  • Department of Veterans Affairs Merit Review Award (I01BX004712, NIMH R01 MH122954, NIH NIGMS U54GM128729)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
alpha7 nicotinic acetylcholine receptor, memantine, major depressive disorder, lipopolysaccharide-induced depression, quinolinic acid, microglial activation, neuroinflammation, hippocampus, prefrontal cortex, cognitive impairment, glutamatergic neurotransmission, antidepressant effects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Effect of an α-7 Nicotinic Allosteric Modulator PNU120596 and NMDA Receptor Antagonist Memantine on Depressive-like Behavior Induced by LPS in Mice: The Involvement of Brain Microglia. https://app.cochat.ai/papers/10.3390/brainsci12111493
The paper
Alzarea, S., Abbas, M., Ronan, P. J., Lutfy, K., & Rahman, S. (2022). The Effect of an α-7 Nicotinic Allosteric Modulator PNU120596 and NMDA Receptor Antagonist Memantine on Depressive-like Behavior Induced by LPS in Mice: The Involvement of Brain Microglia. Brain Sciences. https://doi.org/10.3390/brainsci12111493

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.